Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study in Subjects With Spastic Paraplegia Type 11 Taking Trehalose

NCT04912609 is registered in ClinicalTrials.gov with IRCCS Fondazione Stella Maris as lead sponsor.

NCT NCT04912609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study in Subjects With Spastic Paraplegia Type 11 Taking Trehalose
Lead sponsor
IRCCS Fondazione Stella Maris
Phase
Observational
Overall status
Completed
Start date
June 30, 2021
Completion date
July 30, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary spastic paraplegia, spastic paraplegia type 11